• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Digoxin therapy in patients with long-term digitalis therapy. Comparison of the digoxin blood level after oral administration of digoxin and beta-methyldigoxin].

作者信息

Hennersdorf G, Leithäuser H

出版信息

Fortschr Med. 1980 Mar 20;98(11):(410-2).

PMID:7372228
Abstract

UNLABELLED

The serum digoxin levels of 23 patients were measured by radio immune assay. The patients were divided into 2 groups receiving either 0,5 mg digoxin b.i.d. or 0,25 mg digoxin b.i.d. orally after having been changed from a maintenance dose of 0,2 mg beta-methyl-digoxin b.i.d. The applicated digoxin was the preparation Lenoxin. The question was whether typical or reduced maintenance doses of digoxin in the new preparation reached therapeutic digoxin serum levels in the absence of renal insufficiency.

RESULTS

  1. The maintenance dose of 0,2 mg beta-methyl-digoxin produced stable serum digoxin levels within non-toxic range in all patients; 2. the dosage of 0,5 mg digoxin (group 1) induced accumulation to toxic levels (2,14 mg/ml). A change to 0,25 mg digoxin led to therapeutical serum levels; 3. when using the dosage of 0,25 mg digoxin from the onset of the test (group 2) accumulation was avoided and normal serum digoxin levels were observed during the test period.
摘要

相似文献

1
[Digoxin therapy in patients with long-term digitalis therapy. Comparison of the digoxin blood level after oral administration of digoxin and beta-methyldigoxin].
Fortschr Med. 1980 Mar 20;98(11):(410-2).
2
[Clinical importance of determining the digoxin level in the serum in long-term beta-methyldigoxin treatment].[长期β-甲基地高辛治疗中测定血清地高辛水平的临床意义]
Vutr Boles. 1987;26(6):26-9.
3
[Digitalization without saturation dose using methyldigoxin. Experiences with 29 patients].
Schweiz Med Wochenschr. 1982 Dec 11;112(50):1825-8.
4
[Study of the bioavailability of some digitalis preparations].[某些洋地黄制剂的生物利用度研究]
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna. 1979 May-Jun;31(3):233-42.
5
[Increased digitalis-like activity in combined administration of calcium antagonists and digitalis preparations].[钙拮抗剂与洋地黄制剂联合应用时洋地黄样活性增加]
G Ital Cardiol. 1983 Sep;13(9):188-91.
6
[The importance of body weight in treatment with digoxin and digoxin derivatives (author's transl)].[体重在洋地黄及洋地黄衍生物治疗中的重要性(作者译)]
Dtsch Med Wochenschr. 1977 Jan 28;102(4):116-8. doi: 10.1055/s-0028-1104851.
7
Comparison of medigoxin and digoxin in the control of atrial fibrillation.甲基地高辛与地高辛控制心房颤动的比较。
Br J Clin Pharmacol. 1979 Jul;8(1):53-8. doi: 10.1111/j.1365-2125.1979.tb05909.x.
8
[Another type of interaction between blood levels of digitalis and anti-arrhythmic drugs: digoxin and amiodarone. Experience with long-term therapy].[洋地黄血药浓度与抗心律失常药物之间的另一种相互作用类型:地高辛与胺碘酮。长期治疗经验]
G Ital Cardiol. 1981;11(11):1725-8.
9
[Digoxin versus methylated digoxin in the treatment of cardiac insufficiency].地高辛与甲基地高辛治疗心功能不全的对比研究
An Esp Pediatr. 1988 Sep;29 Suppl 32:218-21.
10
[Pharmacokinetics of beta-methyldigoxin and beta-acetyldigoxin in patients with cirrhosis of the liver (author's transl)].肝硬化患者中β-甲基地高辛和β-乙酰地高辛的药代动力学(作者译)
Wien Klin Wochenschr. 1981 Oct 2;93(18):572-6.